17 Dec 2020 16:00
17 December 2020 16:00 GMT
Â
Transaction by Person Discharging Managerial Responsibilities
Disclosure under Article 19 of the EU Market Abuse Regulation
Â
AstraZeneca PLC (the Company) announces that, on 16 December 2020, it was notified of transactions in the Company's Ordinary Shares of $0.25 each (Ordinary Shares) and American Depositary Shares (ADSs) by certain Persons Discharging Managerial Responsibilities (PDMRs) of the Company as set out below. Two ADSs are equivalent to one Ordinary Share.
Â
PDMR | Position | Nature of the transaction | Quantity | Price |
Michel Demaré | Non-Executive Director | Purchase of Ordinary Shares | 1,300 | GB£76.80 |
Euan Ashley | Non-Executive Director | Purchase of ADSs | 700 | US$51.52 |
Â
Â
Â
The attached notification, made in accordance with the requirements of the EU Market Abuse Regulation, gives further detail.
Â
1  | Details of the person discharging managerial responsibilities / person closely associated  | |||||
a)  | Name   | Michel Demaré | ||||
2  | Reason for the notification  | |||||
a)  | Position/status   | Non-Executive Director | ||||
b)  | Initial notification /Amendment   | Initial notification | ||||
3  | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor  | |||||
a)  | Name   | AstraZeneca PLC | ||||
b) Â | LEI Â Â | PY6ZZQWO2IZFZC3IOL08 | ||||
4  | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted   | |||||
a)  | Description of the financial instrument, type of instrument  Identification code   | Ordinary Shares of US$0.25 each in AstraZeneca PLC   GB0009895292  | ||||
b)  | Nature of the transaction   | Purchase of AstraZeneca PLC Ordinary Shares | ||||
c) Â | Price(s) and volume(s) Â Â | Â
  | ||||
d)  | Aggregated information   - Aggregated volume   - Price   | Not applicable - single transaction  | ||||
e)  | Date of the transaction   | 16 December 2020 | ||||
f)  | Place of the transaction   | XLON |
Â
Â
1  | Details of the person discharging managerial responsibilities / person closely associated  | |||||
a)  | Name   | Euan Ashley | ||||
2  | Reason for the notification  | |||||
a)  | Position/status   | Non-Executive Director | ||||
b)  | Initial notification /Amendment   | Initial notification | ||||
3  | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor  | |||||
a)  | Name   | AstraZeneca PLC | ||||
b) Â | LEI Â Â | PY6ZZQWO2IZFZC3IOL08 | ||||
4  | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted   | |||||
a)  | Description of the financial instrument, type of instrument  Identification code   | AstraZeneca PLC American Depositary Shares   CUSIP: 046353108 | ||||
b)  | Nature of the transaction   | Purchase of AstraZeneca PLC American Depositary Shares | ||||
c) Â | Price(s) and volume(s) Â Â | Â
  | ||||
d)  | Aggregated information   - Aggregated volume   - Price   | Not applicable - single transaction     | ||||
e)  | Date of the transaction   | 16 December 2020 | ||||
f)  | Place of the transaction   | XNAS |
Â
Â
AstraZeneca
AstraZeneca (LSE/STO/Nasdaq: AZN) is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas - Oncology, Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. Please visit astrazeneca.com and follow the Company on Twitter @AstraZeneca.
Contacts
For details on how to contact the Investor Relations Team, please click here. For Media contacts, click here.
Â
Â
Adrian KempCompany Secretary
AstraZeneca PLC
Â